Skip Navigation LinksHome > October/December 2007 - Volume 29 - Issue 4 > Pharmacologic Strategies for the Treatment of Elevated Intra...
Advanced Emergency Nursing Journal:
doi: 10.1097/01.TME.0000300112.24819.5c
Applied Pharmacology

Pharmacologic Strategies for the Treatment of Elevated Intracranial Pressure: Focus on Metabolic Suppression

Cook, Aaron M. PharmD, BCPS; Weant, Kyle A. PharmD, BCPS

Section Editor(s): Scott, Christopher M. PharmD, BCPS

Continued Education
Collapse Box

Abstract

Elevations in intracranial pressure often occur after traumatic brain injury. A limited array of medications is available for the treatment of intracranial hypertension. Metabolic suppression agents may be used in this situation to suppress electrical activity in the brain, diminish the cerebral metabolic rate of oxygen consumption, and, as a consequence, decrease cerebral blood volume and intracranial pressure. Propofol and pentobarbital have unique characteristics that make each desirable, yet difficult to use in the setting of traumatic brain injury. The subject of this review is to discuss the role of these agents in treating refractory elevated intracranial pressure through metabolic suppression.

© 2007 Lippincott Williams & Wilkins, Inc.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.